Leigh Syndrome: A Severe Early-Onset Mitochondrial Brain Disorder
Leigh syndrome is a rare, severe mitochondrial disorder that causes progressive neurological decline in infancy or early childhood due to impaired energy production in the brainstem and basal ganglia.
- Specialist Metabolic & Neurology Review
- Coordinated Multidisciplinary Care
- Access to Genetic Counseling
- Typical Onset Age
- 3-12 months (most common)
- Estimated Prevalence
- ~1 in 40,000 births
- Inheritance Pattern
- Mitochondrial, AR, or X-linked
- Care Approach
- Multidisciplinary Metabolic & Neurologic Care
Condition Overview
Leigh syndrome is a rare, severe mitochondrial disorder characterized by progressive damage to the brainstem, basal ganglia, and other regions of the central nervous system. It results from genetic mutations affecting mitochondrial energy production, with causative variants found in both nuclear and mitochondrial DNA, most commonly in genes such as SURF1 and MT-ATP6.
The condition most often becomes apparent in infancy, typically between 3 and 12 months of age, though onset can occur later in childhood or even adulthood in milder forms. It usually presents with a regression of previously acquired developmental skills alongside feeding difficulties, abnormal movements, and breathing irregularities.
Early and accurate diagnosis is important because it allows families to access specialized metabolic and neurology care, anticipate and manage acute metabolic crises, and receive genetic counseling regarding recurrence risk in future pregnancies.
Types and Genetic Causes
Leigh syndrome can result from mutations in more than 75 different genes, broadly grouped by whether they are located in nuclear DNA or mitochondrial DNA.
Symptoms and Signs
Leigh syndrome typically presents with a progressive loss of previously acquired motor and developmental skills, often triggered or worsened by intercurrent illness.
Causes and Risk Factors
Leigh syndrome arises from genetic mutations that impair mitochondrial energy production, most often affecting the electron transport chain or pyruvate dehydrogenase complex.
Diagnosis and Investigations
Diagnosing Leigh syndrome combines characteristic clinical features, brain imaging, biochemical testing, and confirmatory genetic analysis.
Disease Severity Stratification
Leigh syndrome is not staged like cancer; clinicians instead stratify severity based on neurological function, frequency of metabolic crises, and respiratory involvement.
Standard Treatment Approach
There is no cure for Leigh syndrome, so treatment focuses on supporting metabolic stability, managing symptoms, and preventing or treating crises triggered by illness.
Advanced and Emerging Treatment Options
Research into Leigh syndrome continues to explore therapies aimed at supporting mitochondrial function and, for select genetic causes, gene-targeted approaches.
Precision Medicine
Mitochondrial cofactor combination therapy
Some specialists use combinations of vitamins and cofactors to support residual mitochondrial function, though evidence for disease modification varies.
Gene Therapy
Gene-specific research therapies
Early-stage gene therapy research is being explored for specific genetic causes of Leigh syndrome, such as certain nuclear gene defects.
Respiratory Support
Non-invasive or invasive ventilatory support
Advanced respiratory support may be needed for children with significant brainstem-related breathing dysfunction.
Biomarkers & Diagnostic Markers
Biochemical, imaging, and genetic markers play a central role in confirming a Leigh syndrome diagnosis and monitoring disease activity.
When a Second Opinion May Be Important
Given the complexity and rarity of Leigh syndrome, specialist input can meaningfully shape management decisions.
Clinical Trials & Research
Prognosis & Outcome Factors
Outcomes in Leigh syndrome vary considerably depending on the underlying genetic cause, age of onset, and how effectively metabolic crises are prevented and managed.
Supportive Care and Living With Leigh Syndrome
Ongoing supportive care helps families manage the daily impact of Leigh syndrome and respond effectively during periods of illness.
How CancerFax Helps You Explore Treatment Options
CancerFax helps families of children with Leigh syndrome access specialist metabolic and neurology review, coordinate second opinions, and connect with centers experienced in rare mitochondrial brain disorders.
Get a free case reviewFrequently Asked Questions
Leigh syndrome is a rare, severe genetic disorder that causes progressive damage to the brainstem and basal ganglia due to impaired mitochondrial energy production.
It is caused by mutations in any of more than 75 genes, located in either nuclear or mitochondrial DNA, that disrupt mitochondrial energy production.
Early signs often include loss of previously acquired motor skills, poor feeding, abnormal eye movements, and breathing irregularities, usually appearing in infancy.
Diagnosis combines clinical features, characteristic brain MRI findings, biochemical testing such as lactate levels, and confirmatory genetic testing.
Yes, it can be inherited in autosomal recessive, X-linked, or mitochondrial (maternal) patterns depending on the specific gene involved.
There is currently no cure. Management focuses on metabolic stabilization, symptom management, and preventing crises triggered by illness.
Illness can increase metabolic stress and trigger rapid neurological decline, so families are advised to have an emergency action plan in place.
Yes, genetic counseling helps families understand recurrence risk and informs decisions about future pregnancies.
Care usually involves pediatric neurology, metabolic genetics, respiratory medicine, and nutrition specialists working together.
Yes. CancerFax can help families obtain expert review of medical and genetic reports, coordinate second opinions, connect with specialists experienced in mitochondrial brain disorders, and support cross-border coordination when seeking advanced care.
Get Expert Guidance for Leigh Syndrome
Send your child's medical reports for specialist review and explore coordinated care options for Leigh syndrome.